Citigroup’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
+51,800
New +$1.39M ﹤0.01% 3016
2026
Q1
Sell
-18,000
Closed -$584K 6134
2025
Q4
$584K Hold
18,000
﹤0.01% 3495
2025
Q3
$1.02M Buy
+18,000
New +$922K ﹤0.01% 3148
2025
Q2
Sell
-128,000
Closed -$3.78M 5758
2025
Q1
$3.78M Buy
128,000
+53,700
+72% +$1.99M ﹤0.01% 2170
2024
Q4
$1.8M Buy
74,300
+54,300
+272% +$1.35M ﹤0.01% 2905
2024
Q3
$368K Buy
+20,000
New +$358K ﹤0.01% 3924

Other funds holding HIMS

Citigroup's HIMS Position: Q2 2026 in Review

Citigroup reduced its Hims & Hers Health (HIMS) stake by 66% in Q2 2026, selling an estimated $11.8M and leaving 222,301 shares worth $7.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Citigroup first reported a position in HIMS in Q1 2021 and has held it in 22 quarters since. The position peaked at $15.4M in Q3 2025. 507 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Citigroup held 222,301 shares of Hims & Hers Health worth $7.71M as of Q2 2026.
  • Citigroup sold 440,627 Hims & Hers Health shares in Q2 2026, an estimated $11.8M.
  • Hims & Hers Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1793 holding.
  • Citigroup first reported a position in Hims & Hers Health in Q1 2021 and has held it in 22 quarters since.
  • Citigroup's Hims & Hers Health position peaked at $15.4M in Q3 2025.
  • 507 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.